The Phoenix City Council voted unanimously to provide seed funding for a technology medical and life science accelerator at the University of Arizona on the Phoenix Biomedical Campus.
Author Archive: AZBio
Six Arizona bioscience firms selected for Flinn Foundation entrepreneurship program
Six Arizona bioscience startup firms have been competitively selected by the Flinn Foundation to participate in its 2018 Bioscience Entrepreneurship Program, receiving $30,000 each in funding support and program services administered through a nonprofit partner.Continue reading
UA Study: Brain Liquefaction After Stroke is Toxic to Surviving Brain
Researchers at the University of Arizona College of Medicine – Tucson suggest liquefied brain fluid may be one cause of dementia after stroke.Continue reading
Sinema Passes Bill to Cut Red Tape, Help Arizona Companies Making Life-Saving Breakthroughs
Legislation will create jobs, grow Arizona businesses in biomedicine, science
“The goal of this bill is to ensure that more dollars continue to go to R&D and job creation and less to unnecessary red tape” ~ Joan Koerber-Walker, President & CEO, AZBioContinue reading
Cancer-fighting nanorobots programmed to seek and destroy tumors
Study shows first applications of DNA origami for nanomedicine Continue reading
Freedom From Cancer Start Up Challenge
The Center for Advancing Innovation and MedImmune have partnered to launch the Freedom from Cancer Startup Challenge (FCSC). The FCSC will feature risk mitigated, and commercially viable inventions from leading research organizations. Continue reading
AZBio In The Loop for the week of February 12, 2018
News and events for Arizona’s Biotech Community
|
AZBio CEO Joins Bob Roth on Health Futures
Joan Koerber-Walker, president & CEO of AZBio, joined Bob Roth, Managing Partner of Cypress Homecare Solutions, to discuss the exciting things happening in Arizona’s bioscience and healthcare community on HEALTH FUTURES radio show.Continue reading
bioSyntagma Awarded NSF Phase II Small Business Research Grant
Phoenix, AZ— bioSyntagma, LLC, a developer of life science tools for single and multi-cell analysis announced today it has been has been awarded a National Science Foundation (NSF) Phase II Small Business Innovation Research (SBIR) grant of $735,139.Continue reading